Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 69 Neoplasms 21 Breast Neoplasms 21 Fallopian Tube Neoplasms 18 Prostatic Neoplasms 15 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Endometrial Neoplasms 8 Carcinoma, Ovarian Epithelial 8 Glioblastoma 7 Triple Negative Breast Neoplasms 6 Lung Neoplasms 5 Small Cell Lung Carcinoma 4 Glioma 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Mesothelioma 3 Melanoma 3 Head and Neck Neoplasms 3 Cystadenocarcinoma, Serous 3 Cholangiocarcinoma 3 Carcinoma 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Stomach Neoplasms 2 Solid Tumor 2 Sarcoma 2 Prostatic Neoplasms, Castration-Resistant 2 Ovarian Diseases 2

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × niraparib × Clear all

NCT07059676 2025-07-11

LIBINI-1

Clinica Universidad de Navarra, Universidad de Navarra

Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡